Torres LA, Bustamante IJI, Torres RA, Oliva PJC, Morales PMÁ, Román BE

Language: Spanish
References: 16
Page: 71-76
PDF size: 229.29 Kb.

ABSTRACT

Background: Cervical cancer is the most common and most lethal gynecological cancer in Mexico.
Objective: To show epidemiological aspects of patients with cervical cancer treated at General Hospital of Mexico with Seguro Popular (free of cost health plan).
Material and method: A retrospective, observational and descriptive study of files from patients with cervical cancer treated at General Hospital of Mexico, from January 2005 to December 2008.
Results: We attended 1,217 patients, 69% of them came from some state of the country; 725 (59%) only had basic studies and 181 (15%) didn’t study; 692 (57%) had their first intercourse before 18 years old; 772 (63%) had more than three children and 629 (55%) never had made a cervical cytology; 1,090 (89%) had diagnosis of squamous cell carcinoma and 127 (11%) adenocarcinomas; 990 (81%) were invasive carcinomas and 227 (19%) in situ; 580 patients (51%) had FIGO stages 0 and I, and 555 (49%) stages II-IV. For stages 0, the median age was 35 years, for stage I, 42 years; 50 years for stage II, 54 for stage III and 51 for stage IV.
Conclusions: This study showed that 69% of the patients came from some state of the country, a frequency of carcinomas in situ lesser than reported at other series in this country and 49% of advanced stages. Most patients had risk factors reported for this disease.

REFERENCES

1. Hughes HS, Steller MA. Radical gynecologic surgery for cancer. Surg Oncol Clin N Am 2005;14:607-631.

2. Hacker FN, Friedlander ML. Cáncer cervical. En: Berek SJ, Hacker FN, eds. Oncología ginecológica. 5a ed. Filadelfia: Lippincott Williams and Wilkins, 2010;341-376.

3. Caro LJ, Zúñiga C. Perfil epidemiológico del cáncer cervicouterino en México. Rev Enf Inf Ped 2009;XXIII:36-37.

4. Tovar GVJ, Ortiz CF, Jiménez GFR, Valencia VG. Panorama epidemiológico de la mortalidad por cáncer cervicouterino en México (1980-2004). Rev Fac Med UNAM 2008;51:47-51.

5. Torres PS, Gutiérrez SJ, Morales GJA. Cáncer en México: Correlación entre los factores socioeconómicos y la alimentación. Med Int Mex 2006;22:336-343.

6. Campion JM. Enfermedad preinvasiva del cuello uterino En: Berek SJ, Hacker FN, eds. Oncología ginecológica. 5ª ed. Filadelfia: Lippincott Williams and Wilkins Philadelphia, 2010;268-284.

7. Eifel JP, Berek SJ, Markman AM. Carcinoma of the Cervix. In: DeVita, Hellman & Rosenberg’s Cancer: Principles & Practice of Oncology, 8th ed. Philadelphia: Lippincot-Raven, 2008;1497-1450.

8. Cáncer cervicouterino. México: Secretaría de Salud, 2004;34-35.

9. Fernández CSB, León AG, Herrera TMC, Salazar SE y col. Perfil epidemiológico de los tumores malignos en México. Dirección General de Epidemiología, Secretaría de Salud, México DF. (SINAIS/SINAVE/DGE/Salud) 2011;46-138.

10. Modificación a la Norma Oficial Mexicana NOM014-SSA2-1994, para la Prevención, detección, diagnóstico, tratamiento y control del cáncer cervicouterino. México: Secretaría de Salud, 2007;10-14.

11. Palacio MSF, Lazcano PE, Allen LB, Hernández AM. Diferencias regionales en la mortalidad por cáncer de mama y cérvix en México. Salud Publica Mex 2009;51(suppl 2):S208-219.

12. Herzog J, Monk JB. Reducing the burden of glandular carcinomas of the uterine cervix. Am J Obstet Gynecol 2007;197:566-571.

13. Hildesheim A, Berrington GA. Etiology and prevention of cervical adenocarcinomas. J Natl Cancer Inst 2006;98:292-293.

14. Dirección General de Estadística e Información. Secretaría de Salud (DGE-SSA, México). Registro Histopatológico de Neoplasias 2000. México: DGE-SSA, 2000;7-8.

15. DiSaia PJ, Creasman TW. Preinvasive disease of the cervix. In: DiSaia PJ, Creasman TW, eds. Clinical gynecologyc oncology. 6th ed. St. Louis: Mosby, 2002;1-33.

16. Torres LA, Gómez GG, Piñón CRA, Torres RA y col. Cáncer cervicouterino en el Hospital General de México, OD: Frecuencia de sus etapas clínicas y su correlación con la edad. GAMO 2007;6:28-32.